QuietStrideLEARNING

CANADIAN PHYSIOTHERAPY · REASONING GUIDE

Subgroup effects: compare the effects, not their significance labels

Worked subgroup estimates show why significant in one group and not in another does not establish a difference, followed by a transfer calculation and credibility check.

Prepared with AI assistance · Review method and limits

A rehabilitation paper reports a statistically significant benefit in one subgroup and a nonsignificant result in another. The discussion says the programme “only works” for the first group.

That conclusion has skipped a comparison. A test within each subgroup asks whether its effect differs from a reference value. An interaction analysis asks whether the effects differ from each other. The answers need not agree.

The studies, outcomes and numbers in this article are original fictional teaching examples. They do not identify a subgroup that should receive or avoid a real treatment.

Begin with the contrast that matches the claim

Suppose a fictional trial measures a 0–100 ability score at twelve weeks. Higher values indicate better ability. Effects are new programme minus comparator, so positive differences favour the new programme.

Investigators prespecified two nonoverlapping subgroups using symptom duration recorded before randomization. To keep the arithmetic transparent, the supplied effect estimates are independent and their sampling distributions are treated as approximately normal.

Baseline subgroup Estimated effect Standard error Approximate 95% interval
Shorter duration +4 points 1.5 points +1.06 to +6.94
Longer duration +3 points 2 points −0.92 to +6.92

The first interval excludes zero. The second does not. Yet the estimated effects are only one point apart, and their uncertainty is substantial.

Altman and Bland describe the direct comparison of independent estimates and the corresponding interaction calculation. The general lesson is to test the difference between effects rather than compare separate significance decisions. Interaction revisited: the difference between two estimates.

Work through the interaction

For this specific simplified example:

difference between effects = 4 − 3 = 1 point

SE of that difference = √(1.5² + 2²) = 2.5 points

approximate 95% interval = 1 ± 1.96 × 2.5 = −3.9 to +5.9 points

The interval includes zero and differences in either direction. The data do not provide convincing evidence that the programme effect differs between these duration groups under this analysis. They also do not establish that the effects are identical: differences of several points remain compatible with the estimates.

“Only works in the shorter-duration group” is therefore not justified. The longer-duration estimate is positive, and its interval includes effects similar to the shorter-duration estimate. Its failure to cross a significance threshold can reflect imprecision rather than an absence of benefit.

For this exercise, a useful sentence is: “Separate subgroup intervals differ in whether they exclude zero, but the direct interaction estimate is one point with an interval from −3.9 to +5.9.” It states the actual comparison without turning uncertainty into certainty.

Notice the assumptions behind the shortcut

The square-root formula above assumes independent estimates. If the subgroups overlap, the same participants contribute repeatedly, or the estimates share a comparator in a way that creates dependence, their covariance matters. An appropriate model or analysis must account for that structure.

The effect scale matters too. These are differences on one continuous scale. Comparing risk ratios usually requires an interaction calculation on the log-ratio scale; subtracting two risk ratios and copying this standard-error formula would not reproduce the analysis.

A published interaction estimate from a suitable prespecified model is generally more useful than reconstructing one from rounded figures. In a real appraisal, inspect the model, subgroup definition and uncertainty instead of treating the arithmetic here as a universal calculator.

A stronger interaction still needs a credibility argument

Statistical evidence of interaction is one part of a subgroup claim. Sun and colleagues describe additional considerations, including baseline rather than postrandomization subgroup definition, prespecification, the number of hypotheses examined, consistency and a plausible rationale. These are credibility considerations, not a mechanical guarantee. Is a subgroup effect believable?.

Imagine our fictional investigators first inspected twenty possible definitions, including several duration cutoffs, and reported only the most favourable one. The chosen contrast would carry a different evidential status from a single hypothesis specified before results were available. A neat explanation written afterwards would not turn the exploration into confirmation.

Now imagine a subgroup defined by completing at least eight sessions. That characteristic occurs after randomization and may be influenced by the programme and by prognosis. Comparing treatment effects among selected completers would require a more careful causal analysis; the original randomization does not automatically protect that selected comparison.

Conversely, a well-planned interaction can remain imprecise. “Prespecified” improves transparency; it does not manufacture information. Read the uncertainty and the design together.

Different effects can appear on different scales

Consider another original numerical example with an undesirable event. Suppose the new programme halves risk in each of two baseline-risk groups:

Group Comparator risk New-programme risk Risk ratio Absolute risk reduction
Higher baseline risk 20% 10% 0.5 10 percentage points
Lower baseline risk 4% 2% 0.5 2 percentage points

There is no difference between the supplied risk ratios, but the absolute reductions differ by eight percentage points. Saying “there is no subgroup difference” without naming the scale would hide useful information. The example follows directly from the supplied risks; it is not a claim that a constant risk ratio applies in every study.

For a decision, an absolute benefit can matter even when the relative effect is similar. For an interaction hypothesis, the planned scale determines what equality means. Do not change the scale after examining results merely to obtain a more attractive subgroup story.

Transfer exercise: calculate, then qualify

A second fictional trial supplies independent subgroup estimates of +6 points with SE 1, and 0 points with SE 1. Use the same normal approximation. What does the direct interaction calculation show? What changes if the subgroup definition was selected after examining twenty candidate analyses?

Reasoned solution: The difference is six points. Its SE is √(1² + 1²), approximately 1.414 points. The approximate 95% interval is 6 ± 1.96 × 1.414, or +3.23 to +8.77 points. This provides statistical evidence of different effects on the specified scale under the stated assumptions.

If the definition was selected after twenty analyses, the calculation itself does not change, but the unadjusted interval does not account for that selection process. The claim becomes exploratory and needs cautious interpretation, appropriate consideration of multiplicity, and further evidence. It would be misleading to present it as a uniquely prespecified confirmation.

The opposite error would be dismissing every subgroup analysis because some are unreliable. A direct, precise, well-supported comparison can be informative. The task is to describe the strength and limits of this particular claim.

Takeaway for your next journal discussion

Before repeating a subgroup headline, identify the effect scale, the interaction estimate and interval, when the subgroup was defined, and how many alternatives were examined. Replace “significant here, nonsignificant there” with the actual estimated difference between effects. That one change makes the reasoning easier to evaluate.

Sources and further reading

Editorial method and limits

Prepared with AI assistance for QuietStride. An additional AI review checked source alignment, reasoning, calculations where relevant, alternative interpretations and worked examples. Evidence last checked on . This is an AI review; no independent human clinical or subject approval is claimed.

This article supports education and supervised learning. It does not assess an individual patient, prescribe treatment or authorize professional practice. Use current local requirements and qualified supervision for clinical decisions.

Sources support the specific claims cited; they do not validate every original teaching method. Some source checks used an abstract or indexed excerpt where full text was unavailable. Provider policies and professional standards can change. Report a correction or unclear explanation.

Source access record
← Browse all 95 articles